HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enrica Martinelli Selected Research

Colorectal Neoplasms (Colorectal Cancer)

5/2012Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Enrica Martinelli Research Topics

Disease

19Neoplasms (Cancer)
04/2020 - 07/2003
18Ovarian Neoplasms (Ovarian Cancer)
04/2020 - 07/2003
5Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2014 - 05/2004
3Endometrial Neoplasms (Endometrial Cancer)
06/2021 - 09/2005
2Neoplasm Metastasis (Metastasis)
01/2017 - 10/2016
1Starvation
05/2012
1Colorectal Neoplasms (Colorectal Cancer)
05/2012
1Medulloblastoma
10/2010
1Hypoglycemia (Reactive Hypoglycemia)
07/2010
1Residual Neoplasm
11/2008
1Carcinosarcoma
02/2007
1Adenocarcinoma
02/2007
1Atrophy
01/2006
1Stomach Neoplasms (Stomach Cancer)
09/2004

Drug/Important Bio-Agent (IBA)

9TubulinIBA
04/2018 - 01/2005
6Proteins (Proteins, Gene)FDA Link
10/2016 - 07/2003
4Pharmaceutical PreparationsIBA
06/2021 - 07/2003
4Paclitaxel (Taxol)FDA LinkGeneric
07/2006 - 07/2003
3Biomarkers (Surrogate Marker)IBA
06/2021 - 03/2012
3PlatinumIBA
11/2008 - 05/2006
2ProgesteroneFDA LinkGeneric
01/2017 - 09/2005
2Estrogens (Estrogen)FDA Link
02/2016 - 09/2005
2Messenger RNA (mRNA)IBA
08/2015 - 07/2010
2Biological ProductsIBA
06/2009 - 02/2007
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2005 - 05/2004
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
04/2020
1Long Noncoding RNAIBA
04/2020
1TensinsIBA
04/2020
1AntibodiesIBA
04/2018
1Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
01/2017
1Androgen Receptors (Androgen Receptor)IBA
01/2017
1Hormones (Hormone)IBA
01/2017
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
10/2016
1SurvivinIBA
09/2014
1A-factor (Streptomyces)IBA
02/2013
1MicroRNAs (MicroRNA)IBA
02/2013
1epothilone B (EPO906)IBA
12/2012
1Transcription Factors (Transcription Factor)IBA
12/2012
1Epothilones (Epothilone)IBA
12/2012
1Androgen Antagonists (Antiandrogens)IBA
05/2012
1AndrogensIBA
05/2012
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2012
1AdrenomedullinIBA
01/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2010
1AEE 788 (AEE788)IBA
10/2010
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
10/2010
1Glucose (Dextrose)FDA LinkGeneric
07/2010
1Oxygen (Dioxygen)IBA
07/2010
1AC133 AntigenIBA
07/2009
1CRF receptor type 2IBA
06/2009
1Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA
06/2009
1RON proteinIBA
11/2008
1EnzymesIBA
07/2006
1Arachidonic Acid (Vitamin F)IBA
07/2006
1ProstaglandinsIBA
07/2006
1Biological FactorsIBA
04/2006
1Celecoxib (Celebrex)FDA Link
04/2006
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
04/2006
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
04/2006
1Tryptases (Tryptase)IBA
04/2006
1CytokinesIBA
04/2006
1salicylhydroxamic acid (SHAM)IBA
01/2006
1Cadherins (E-Cadherin)IBA
09/2004
1DNA (Deoxyribonucleic Acid)IBA
09/2004
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
05/2004

Therapy/Procedure

5Drug Therapy (Chemotherapy)
01/2017 - 05/2006
2Therapeutics
10/2016 - 05/2006
2Neoadjuvant Therapy
04/2010 - 05/2004
1Estrogen Replacement Therapy
02/2016
1Chemoradiotherapy
02/2007